These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 18096854)

  • 1. Myasthenia gravis experimentally induced with muscle-specific kinase.
    Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
    Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenic mechanisms of myasthenia gravis induced by antibodies against muscle-specific kinase].
    Maruyama N; Shigemoto K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):842-4. PubMed ID: 18210813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of myasthenia by immunization against muscle-specific kinase.
    Shigemoto K; Kubo S; Maruyama N; Hato N; Yamada H; Jie C; Kobayashi N; Mominoki K; Abe Y; Ueda N; Matsuda S
    J Clin Invest; 2006 Apr; 116(4):1016-24. PubMed ID: 16557298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis.
    Mori S; Yamada S; Kubo S; Chen J; Matsuda S; Shudou M; Maruyama N; Shigemoto K
    J Neuroimmunol; 2012 Mar; 244(1-2):1-7. PubMed ID: 22222307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
    Viegas S; Jacobson L; Waters P; Cossins J; Jacob S; Leite MI; Webster R; Vincent A
    Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synaptic muscle-specific kinase (MuSK) complex: new partners, new functions.
    Strochlic L; Cartaud A; Cartaud J
    Bioessays; 2005 Nov; 27(11):1129-35. PubMed ID: 16237673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myasthenia gravis induced by autoantibodies against MuSK].
    Shigemoto K; Konishi T; Ohta M
    Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphatase regulation of MuSK-dependent acetylcholine receptor clustering.
    Madhavan R; Zhao XT; Ruegg MA; Peng HB
    Mol Cell Neurosci; 2005 Mar; 28(3):403-16. PubMed ID: 15737732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphatases such as SHP-2 act in a balance with Src-family kinases in stabilization of postsynaptic clusters of acetylcholine receptors.
    Camilleri AA; Willmann R; Sadasivam G; Lin S; Rüegg MA; Gesemann M; Fuhrer C
    BMC Neurosci; 2007 Jul; 8():46. PubMed ID: 17605785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seronegative myasthenia gravis.
    Vincent A; McConville J; Farrugia ME; Newsom-Davis J
    Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of muscle-specific kinase MuSK with the acetylcholine receptor in mammalian muscle.
    Fuhrer C; Sugiyama JE; Taylor RG; Hall ZW
    EMBO J; 1997 Aug; 16(16):4951-60. PubMed ID: 9305637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to agrin in myasthenia gravis patients.
    Zhang B; Shen C; Bealmear B; Ragheb S; Xiong WC; Lewis RA; Lisak RP; Mei L
    PLoS One; 2014; 9(3):e91816. PubMed ID: 24632822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice.
    Cole RN; Ghazanfari N; Ngo ST; Gervásio OL; Reddel SW; Phillips WD
    J Physiol; 2010 Sep; 588(Pt 17):3217-29. PubMed ID: 20603331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
    Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
    Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
    Koneczny I; Cossins J; Waters P; Beeson D; Vincent A
    PLoS One; 2013; 8(11):e80695. PubMed ID: 24244707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity.
    Punga AR; Maj M; Lin S; Meinen S; Rüegg MA
    Eur J Neurosci; 2011 Mar; 33(5):890-8. PubMed ID: 21255125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Overview: MuSK/Dok-7].
    Motomura M; Fukuda T; Yoshimura T; Tsujihata M
    Nihon Rinsho; 2008 Jun; 66(6):1140-8. PubMed ID: 18540360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.